AzTrials
AzTrials

Colonoscopy FailurePhase 4NCT01510977

Second Bowel Preparation for Colonoscopy Failure

A Phase 4 study testing polyethylene glycol, Bisacodyl and polyethylene glycol in people with Colonoscopy Failure and Poor Bowel Preparation, run by Asan Medical Center at 1 site in South Korea.

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

Colonoscopy is a basic but important tool to diagnose and treat lesions of the colon. Proper colon cleansing is essential for colonoscopy to be performed with a good quality. Inadequate bowel preparation leads to longer colonoscopic insertion time and patient discomfort, as well as inadequate diagnostic yield of… Read more about this study

Who is it for?
Ages 18 years and olderHealthy volunteers can take part
Conditions the study is for
Colonoscopy Failure, Poor Bowel Preparation
What is being tested?
polyethylene glycol, Bisacodyl and polyethylene glycol
Could I receive a placebo?
No, everyone receives an active treatment
How many people
150 participants
Where
1 siteSouth Korea
Study dates
Nov 2011to Feb 2013
Phase
Phase 4
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • Healthy volunteers accepted
  • Adult, Older adult

Who may be able to join

  • First colonoscopy failure due to inadequate bowel preparation

Who cannot join

  • younger than 18 years old
  • presence of inflammatory bowel disease
  • pregnant
  • lactating
  • refusal

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Asan Medical Center

    Seoul, 138-736

Other trials in South Korea

About this study

Official title: The Outcome of a Second Preparation for Colonoscopy After Preparation Failure in the First Procedure: a Prospective Randomized Controlled Study

Colonoscopy is a basic but important tool to diagnose and treat lesions of the colon. Proper colon cleansing is essential for colonoscopy to be performed with a good quality. Inadequate bowel preparation leads to longer colonoscopic insertion time and patient discomfort, as well as inadequate diagnostic yield of colonic lesions. Frequency of colonoscopy failure due to bad bowel preparation is reported to be 0.3% to 6.5 percent, and the rate increases with liver cirrhosis, constipation, dementia, stroke, or administration of tricyclic antidepressants. In case of colonoscopy failure due to bad bowel preparation, the second colonoscopy can be performed with either adding a colon cleansing solution immediately, or it can be performed after a few days with colon cleansing agent together with prokinetics. These different kinds of bowel preparations after first colonoscopy failure have not been compared.

Being tested
polyethylene glycol, Bisacodyl, polyethylene glycol
Keywords
colonoscopy, bowel preparation

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • polyethylene glycol, BisacodylDrug

    After failure of first colonoscopy, bowel preparation with polyethylene glycol and bisacodyl one week after

  • polyethylene glycolDrug

    Immediately after first colonoscopy failure, polyethylene glycol 2L addition

Study groups in NCT01510977
Study groupRoleWhat they receive
PEGActive comparator2L of polyethylene glycol addition immediately after first colonoscopy failure
Receives: Drug: polyethylene glycol
PEG + bisacodylExperimentalOne week after initial colonoscopy failure, conventional amount (5L) of polyethylene glycol together with bisacodyl administration
Receives: Drug: polyethylene glycol, Bisacodyl

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. second colonoscopy failure due to inadequate bowel preparation (PEG+bisdacodyl group)

    Measured: one week

  2. second colonoscopy failure due to inadequate bowel preparation (PEG group)

    Measured: within the same day

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted18 Jan 2012 (estimated)
  2. Study startNov 2011
  3. Primary completionFeb 2013
  4. Study completionFeb 2013

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase 4
Primary purpose
Diagnosis
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
150 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT01510977
Sponsor's protocol ID
2009-0733
Status last verified
Feb 2013
First submitted
9 Jan 2012
Last updated
13 Feb 2013
Results posted
No
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A Phase 4 study testing polyethylene glycol, Bisacodyl and polyethylene glycol in people with Colonoscopy Failure and Poor Bowel Preparation, run by Asan Medical Center at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 5 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 13 Feb 2013. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

What does this phase mean?

Phase 4 studies take place after a treatment is approved, to learn more about its long-term benefits and risks in everyday use.

Not every study follows the same path, and some studies (observational studies, device studies) have no phase.

Are results available for this study?

The study was stopped early. Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

second colonoscopy failure due to inadequate bowel preparation (PEG+bisdacodyl group) (time frame: one week). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 13 Feb 2013.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in